お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は複合処方市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは複合処方の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の複合処方市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは複合処方のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に複合処方市場を分類しています。本研究に含まれる主な企業は：PharMEDium Services、B. Braun Group、Fagron、Wedgewood Pharmacy、New Compounding Pharma、Medisca、Fresenius Kabi、Advanced Pharma、AIN GROUP、Nihon Chouzai、Sogo Medical、Dougherty’s Pharmacy、Apollo Pharmacy、Downing Labs、Qol Holdings、Olympia Pharmacy、PUMCH、Triangle Compounding Pharmacy、Peking University First Hospital、Affiliated Hospital of Guangdong Public Institution of Medicine、Lorraine's Pharmacy、PLAGH、Institutional Pharmacy Solutions、Ruijin Hospital、Belle Sante、Byculla Pharmacy&Stores、Royal Chemists、Village Compounding Pharmacy、Specialist Pharmacy

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    PIA
    PAA
    CUPM
    PDA
    SAPM

用途別の市場セグメント：
    Consumers Aged 18 and Younger
    Consumers Aged 19 to 44
    Consumers Aged 45 to 64
    Consumers Aged 65 and Older

本レポートの詳細内容
世界の複合処方市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、複合処方タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の複合処方収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の複合処方市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、複合処方市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

複合処方のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：複合処方のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：複合処方の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章複合処方企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：複合処方の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：複合処方の主要企業の概要を提供し、製品の説明と仕様、複合処方の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs. For example: A young child may need a small, liquid dose of a drug made only in adult-dosage tablets. A person may be allergic to one of the ingredients in the commercial version of a drug. A compounding pharmacy would make the proper dosage and form of the drug without any offending ingredients. Compounded medications are made based on a practitioner’s prescription in which individual ingredients are mixed together in the exact strength and dosage form required by the patient. This method allows the compounding pharmacist to work with the patient and the prescriber to customize a medication to meet the patient’s specific needs.
The global Compounding Pharmacy market is projected to grow from US$ 12200 million in 2024 to US$ 14310 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.7% during the forecast period.
The key drivers in the compounding pharmacy market is the increasing demand for personalized medications. As healthcare becomes more tailored to individual patient needs, there is a growing preference for custom formulations, especially for those who are allergic to standard treatments, require specific dosages, or need medications that have been discontinued. Compounding pharmacies offer a solution by creating medications that are not available in mass production, meeting the unique requirements of patients, which significantly boosts market growth.However, the market faces significant challenges, primarily in the form of stringent regulatory standards. Compounded drugs are not subject to the same FDA approval process as mass-produced medications, which raises concerns about safety, efficacy, and quality control. Additionally, the cost and complexity of maintaining compliance with state and federal regulations can be a barrier for smaller pharmacies, limiting market expansion and innovation.
Global Compounding Pharmacy key players include Fagron, Wedgewood Pharmacy, CAPS, Fresenius Kabi, Advanced Pharma, etc. Global top five manufacturers hold a share nearly 5%. North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.  In terms of product, PIA is the largest segment, with a share over 30%. And in terms of application, the largest application is Consumers Aged 45 to 64, followed by Consumers Aged 65 and Older, Consumers Aged 19 to 44, Consumers Aged 18 and Younger.
Report Includes
This report presents an overview of global market for Compounding Pharmacy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Compounding Pharmacy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Compounding Pharmacy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Compounding Pharmacy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Compounding Pharmacy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Compounding Pharmacy revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including PharMEDium Services, B. Braun Group, Fagron, Wedgewood Pharmacy, New Compounding Pharma, Medisca, Fresenius Kabi, Advanced Pharma, AIN GROUP, Nihon Chouzai, etc.
Market Segmentation
By Company
    PharMEDium Services
    B. Braun Group
    Fagron
    Wedgewood Pharmacy
    New Compounding Pharma
    Medisca
    Fresenius Kabi
    Advanced Pharma
    AIN GROUP
    Nihon Chouzai
    Sogo Medical
    Dougherty’s Pharmacy
    Apollo Pharmacy
    Downing Labs
    Qol Holdings
    Olympia Pharmacy
    PUMCH
    Triangle Compounding Pharmacy
    Peking University First Hospital
    Affiliated Hospital of Guangdong Public Institution of Medicine
    Lorraine's Pharmacy
    PLAGH
    Institutional Pharmacy Solutions
    Ruijin Hospital
    Belle Sante
    Byculla Pharmacy&Stores
    Royal Chemists
    Village Compounding Pharmacy
    Specialist Pharmacy

Segment by Type
    PIA
    PAA
    CUPM
    PDA
    SAPM

Segment by Application
    Consumers Aged 18 and Younger
    Consumers Aged 19 to 44
    Consumers Aged 45 to 64
    Consumers Aged 65 and Older

By Region
    North America
        United States
        Canada
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Latin America
        Mexico
        Brazil
        Rest of South America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Compounding Pharmacy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Compounding Pharmacy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Compounding Pharmacy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
 Table 1. Global Compounding Pharmacy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of PIA
 Table 3. Key Players of PAA
 Table 4. Key Players of CUPM
 Table 5. Key Players of PDA
 Table 6. Key Players of SAPM
 Table 7. Global Compounding Pharmacy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 8. Global Compounding Pharmacy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 9. Global Compounding Pharmacy Market Size by Region (2019-2024) & (US$ Million)
 Table 10. Global Compounding Pharmacy Market Share by Region (2019-2024)
 Table 11. Global Compounding Pharmacy Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 12. Global Compounding Pharmacy Market Share by Region (2025-2030)
 Table 13. Compounding Pharmacy Market Trends
 Table 14. Compounding Pharmacy Market Drivers
 Table 15. Compounding Pharmacy Market Challenges
 Table 16. Compounding Pharmacy Market Restraints
 Table 17. Global Compounding Pharmacy Revenue by Players (2019-2024) & (US$ Million)
 Table 18. Global Compounding Pharmacy Market Share by Players (2019-2024)
 Table 19. Global Top Compounding Pharmacy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Compounding Pharmacy as of 2023)
 Table 20. Global Compounding Pharmacy Industry Ranking 2022 VS 2023
 Table 21. Global 5 Largest Players Market Share by Compounding Pharmacy Revenue (CR5 and HHI) & (2019-2024)
 Table 22. Global Key Players of Compounding Pharmacy, Headquarters and Area Served
 Table 23. Global Key Players of Compounding Pharmacy, Product and Application
 Table 24. Global Key Players of Compounding Pharmacy, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Compounding Pharmacy Market Size by Type (2019-2024) & (US$ Million)
 Table 27. Global Compounding Pharmacy Revenue Market Share by Type (2019-2024)
 Table 28. Global Compounding Pharmacy Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 29. Global Compounding Pharmacy Revenue Market Share by Type (2025-2030)
 Table 30. Global Compounding Pharmacy Market Size by Application (2019-2024) & (US$ Million)
 Table 31. Global Compounding Pharmacy Revenue Market Share by Application (2019-2024)
 Table 32. Global Compounding Pharmacy Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 33. Global Compounding Pharmacy Revenue Market Share by Application (2025-2030)
 Table 34. North America Compounding Pharmacy Market Size by Type (2019-2024) & (US$ Million)
 Table 35. North America Compounding Pharmacy Market Size by Type (2025-2030) & (US$ Million)
 Table 36. North America Compounding Pharmacy Market Size by Application (2019-2024) & (US$ Million)
 Table 37. North America Compounding Pharmacy Market Size by Application (2025-2030) & (US$ Million)
 Table 38. North America Compounding Pharmacy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. North America Compounding Pharmacy Market Size by Country (2019-2024) & (US$ Million)
 Table 40. North America Compounding Pharmacy Market Size by Country (2025-2030) & (US$ Million)
 Table 41. Europe Compounding Pharmacy Market Size by Type (2019-2024) & (US$ Million)
 Table 42. Europe Compounding Pharmacy Market Size by Type (2025-2030) & (US$ Million)
 Table 43. Europe Compounding Pharmacy Market Size by Application (2019-2024) & (US$ Million)
 Table 44. Europe Compounding Pharmacy Market Size by Application (2025-2030) & (US$ Million)
 Table 45. Europe Compounding Pharmacy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 46. Europe Compounding Pharmacy Market Size by Country (2019-2024) & (US$ Million)
 Table 47. Europe Compounding Pharmacy Market Size by Country (2025-2030) & (US$ Million)
 Table 48. China Compounding Pharmacy Market Size by Type (2019-2024) & (US$ Million)
 Table 49. China Compounding Pharmacy Market Size by Type (2025-2030) & (US$ Million)
 Table 50. China Compounding Pharmacy Market Size by Application (2019-2024) & (US$ Million)
 Table 51. China Compounding Pharmacy Market Size by Application (2025-2030) & (US$ Million)
 Table 52. Asia Compounding Pharmacy Market Size by Type (2019-2024) & (US$ Million)
 Table 53. Asia Compounding Pharmacy Market Size by Type (2025-2030) & (US$ Million)
 Table 54. Asia Compounding Pharmacy Market Size by Application (2019-2024) & (US$ Million)
 Table 55. Asia Compounding Pharmacy Market Size by Application (2025-2030) & (US$ Million)
 Table 56. Asia Compounding Pharmacy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 57. Asia Compounding Pharmacy Market Size by Region (2019-2024) & (US$ Million)
 Table 58. Asia Compounding Pharmacy Market Size by Region (2025-2030) & (US$ Million)
 Table 59. Middle East, Africa, and Latin America Compounding Pharmacy Market Size by Type (2019-2024) & (US$ Million)
 Table 60. Middle East, Africa, and Latin America Compounding Pharmacy Market Size by Type (2025-2030) & (US$ Million)
 Table 61. Middle East, Africa, and Latin America Compounding Pharmacy Market Size by Application (2019-2024) & (US$ Million)
 Table 62. Middle East, Africa, and Latin America Compounding Pharmacy Market Size by Application (2025-2030) & (US$ Million)
 Table 63. Middle East, Africa, and Latin America Compounding Pharmacy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 64. Middle East, Africa, and Latin America Compounding Pharmacy Market Size by Country (2019-2024) & (US$ Million)
 Table 65. Middle East, Africa, and Latin America Compounding Pharmacy Market Size by Country (2025-2030) & (US$ Million)
 Table 66. PharMEDium Services Company Details
 Table 67. PharMEDium Services Business Overview
 Table 68. PharMEDium Services Compounding Pharmacy Product
 Table 69. PharMEDium Services Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 70. PharMEDium Services Recent Development
 Table 71. B. Braun Group Company Details
 Table 72. B. Braun Group Business Overview
 Table 73. B. Braun Group Compounding Pharmacy Product
 Table 74. B. Braun Group Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 75. B. Braun Group Recent Development
 Table 76. Fagron Company Details
 Table 77. Fagron Business Overview
 Table 78. Fagron Compounding Pharmacy Product
 Table 79. Fagron Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 80. Fagron Recent Development
 Table 81. Wedgewood Pharmacy Company Details
 Table 82. Wedgewood Pharmacy Business Overview
 Table 83. Wedgewood Pharmacy Compounding Pharmacy Product
 Table 84. Wedgewood Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 85. Wedgewood Pharmacy Recent Development
 Table 86. New Compounding Pharma Company Details
 Table 87. New Compounding Pharma Business Overview
 Table 88. New Compounding Pharma Compounding Pharmacy Product
 Table 89. New Compounding Pharma Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 90. New Compounding Pharma Recent Development
 Table 91. Medisca Company Details
 Table 92. Medisca Business Overview
 Table 93. Medisca Compounding Pharmacy Product
 Table 94. Medisca Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 95. Medisca Recent Development
 Table 96. Fresenius Kabi Company Details
 Table 97. Fresenius Kabi Business Overview
 Table 98. Fresenius Kabi Compounding Pharmacy Product
 Table 99. Fresenius Kabi Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 100. Fresenius Kabi Recent Development
 Table 101. Advanced Pharma Company Details
 Table 102. Advanced Pharma Business Overview
 Table 103. Advanced Pharma Compounding Pharmacy Product
 Table 104. Advanced Pharma Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 105. Advanced Pharma Recent Development
 Table 106. AIN GROUP Company Details
 Table 107. AIN GROUP Business Overview
 Table 108. AIN GROUP Compounding Pharmacy Product
 Table 109. AIN GROUP Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 110. AIN GROUP Recent Development
 Table 111. Nihon Chouzai Company Details
 Table 112. Nihon Chouzai Business Overview
 Table 113. Nihon Chouzai Compounding Pharmacy Product
 Table 114. Nihon Chouzai Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 115. Nihon Chouzai Recent Development
 Table 116. Sogo Medical Company Details
 Table 117. Sogo Medical Business Overview
 Table 118. Sogo Medical Compounding Pharmacy Product
 Table 119. Sogo Medical Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 120. Sogo Medical Recent Development
 Table 121. Dougherty’s Pharmacy Company Details
 Table 122. Dougherty’s Pharmacy Business Overview
 Table 123. Dougherty’s Pharmacy Compounding Pharmacy Product
 Table 124. Dougherty’s Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 125. Dougherty’s Pharmacy Recent Development
 Table 126. Apollo Pharmacy Company Details
 Table 127. Apollo Pharmacy Business Overview
 Table 128. Apollo Pharmacy Compounding Pharmacy Product
 Table 129. Apollo Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 130. Apollo Pharmacy Recent Development
 Table 131. Downing Labs Company Details
 Table 132. Downing Labs Business Overview
 Table 133. Downing Labs Compounding Pharmacy Product
 Table 134. Downing Labs Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 135. Downing Labs Recent Development
 Table 136. Qol Holdings Company Details
 Table 137. Qol Holdings Business Overview
 Table 138. Qol Holdings Compounding Pharmacy Product
 Table 139. Qol Holdings Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 140. Qol Holdings Recent Development
 Table 141. Olympia Pharmacy Company Details
 Table 142. Olympia Pharmacy Business Overview
 Table 143. Olympia Pharmacy Compounding Pharmacy Product
 Table 144. Olympia Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 145. Olympia Pharmacy Recent Development
 Table 146. PUMCH Company Details
 Table 147. PUMCH Business Overview
 Table 148. PUMCH Compounding Pharmacy Product
 Table 149. PUMCH Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 150. PUMCH Recent Development
 Table 151. Triangle Compounding Pharmacy Company Details
 Table 152. Triangle Compounding Pharmacy Business Overview
 Table 153. Triangle Compounding Pharmacy Compounding Pharmacy Product
 Table 154. Triangle Compounding Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 155. Triangle Compounding Pharmacy Recent Development
 Table 156. Peking University First Hospital Company Details
 Table 157. Peking University First Hospital Business Overview
 Table 158. Peking University First Hospital Compounding Pharmacy Product
 Table 159. Peking University First Hospital Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 160. Peking University First Hospital Recent Development
 Table 161. Affiliated Hospital of Guangdong Public Institution of Medicine Company Details
 Table 162. Affiliated Hospital of Guangdong Public Institution of Medicine Business Overview
 Table 163. Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Product
 Table 164. Affiliated Hospital of Guangdong Public Institution of Medicine Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 165. Affiliated Hospital of Guangdong Public Institution of Medicine Recent Development
 Table 166. Lorraine's Pharmacy Company Details
 Table 167. Lorraine's Pharmacy Business Overview
 Table 168. Lorraine's Pharmacy Compounding Pharmacy Product
 Table 169. Lorraine's Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 170. Lorraine's Pharmacy Recent Development
 Table 171. PLAGH Company Details
 Table 172. PLAGH Business Overview
 Table 173. PLAGH Compounding Pharmacy Product
 Table 174. PLAGH Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 175. PLAGH Recent Development
 Table 176. Institutional Pharmacy Solutions Company Details
 Table 177. Institutional Pharmacy Solutions Business Overview
 Table 178. Institutional Pharmacy Solutions Compounding Pharmacy Product
 Table 179. Institutional Pharmacy Solutions Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 180. Institutional Pharmacy Solutions Recent Development
 Table 181. Ruijin Hospital Company Details
 Table 182. Ruijin Hospital Business Overview
 Table 183. Ruijin Hospital Compounding Pharmacy Product
 Table 184. Ruijin Hospital Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 185. Ruijin Hospital Recent Development
 Table 186. Belle Sante Company Details
 Table 187. Belle Sante Business Overview
 Table 188. Belle Sante Compounding Pharmacy Product
 Table 189. Belle Sante Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 190. Belle Sante Recent Development
 Table 191. Byculla Pharmacy&Stores Company Details
 Table 192. Byculla Pharmacy&Stores Business Overview
 Table 193. Byculla Pharmacy&Stores Compounding Pharmacy Product
 Table 194. Byculla Pharmacy&Stores Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 195. Byculla Pharmacy&Stores Recent Development
 Table 196. Royal Chemists Company Details
 Table 197. Royal Chemists Business Overview
 Table 198. Royal Chemists Compounding Pharmacy Product
 Table 199. Royal Chemists Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 200. Royal Chemists Recent Development
 Table 201. Village Compounding Pharmacy Company Details
 Table 202. Village Compounding Pharmacy Business Overview
 Table 203. Village Compounding Pharmacy Compounding Pharmacy Product
 Table 204. Village Compounding Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 205. Village Compounding Pharmacy Recent Development
 Table 206. Specialist Pharmacy Company Details
 Table 207. Specialist Pharmacy Business Overview
 Table 208. Specialist Pharmacy Compounding Pharmacy Product
 Table 209. Specialist Pharmacy Revenue in Compounding Pharmacy Business (2019-2024) & (US$ Million)
 Table 210. Specialist Pharmacy Recent Development
 Table 211. Research Programs/Design for This Report
 Table 212. Key Data Information from Secondary Sources
 Table 213. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global Compounding Pharmacy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 2. Global Compounding Pharmacy Market Share by Type: 2023 VS 2030
 Figure 3. PIA Features
 Figure 4. PAA Features
 Figure 5. CUPM Features
 Figure 6. PDA Features
 Figure 7. SAPM Features
 Figure 8. Global Compounding Pharmacy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 9. Global Compounding Pharmacy Market Share by Application: 2023 VS 2030
 Figure 10. Consumers Aged 18 and Younger Case Studies
 Figure 11. Consumers Aged 19 to 44 Case Studies
 Figure 12. Consumers Aged 45 to 64 Case Studies
 Figure 13. Consumers Aged 65 and Older Case Studies
 Figure 14. Compounding Pharmacy Report Years Considered
 Figure 15. Global Compounding Pharmacy Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 16. Global Compounding Pharmacy Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 17. Global Compounding Pharmacy Market Share by Region: 2023 VS 2030
 Figure 18. Global Compounding Pharmacy Market Share by Players in 2023
 Figure 19. Global Top Compounding Pharmacy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Compounding Pharmacy as of 2023)
 Figure 20. The Top 10 and 5 Players Market Share by Compounding Pharmacy Revenue in 2023
 Figure 21. North America Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. North America Compounding Pharmacy Market Share by Type (2019-2030)
 Figure 23. North America Compounding Pharmacy Market Share by Application (2019-2030)
 Figure 24. North America Compounding Pharmacy Market Share by Country (2019-2030)
 Figure 25. United States Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. Canada Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Europe Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Europe Compounding Pharmacy Market Share by Type (2019-2030)
 Figure 29. Europe Compounding Pharmacy Market Share by Application (2019-2030)
 Figure 30. Europe Compounding Pharmacy Market Share by Country (2019-2030)
 Figure 31. Germany Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. France Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. U.K. Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Italy Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Russia Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Nordic Countries Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. China Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. China Compounding Pharmacy Market Share by Type (2019-2030)
 Figure 39. China Compounding Pharmacy Market Share by Application (2019-2030)
 Figure 40. Asia Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Asia Compounding Pharmacy Market Share by Type (2019-2030)
 Figure 42. Asia Compounding Pharmacy Market Share by Application (2019-2030)
 Figure 43. Asia Compounding Pharmacy Market Share by Region (2019-2030)
 Figure 44. Japan Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. South Korea Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. China Taiwan Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Southeast Asia Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. India Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Australia Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 50. Middle East, Africa, and Latin America Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 51. Middle East, Africa, and Latin America Compounding Pharmacy Market Share by Type (2019-2030)
 Figure 52. Middle East, Africa, and Latin America Compounding Pharmacy Market Share by Application (2019-2030)
 Figure 53. Middle East, Africa, and Latin America Compounding Pharmacy Market Share by Country (2019-2030)
 Figure 54. Brazil Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 55. Mexico Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 56. Turkey Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 57. Saudi Arabia Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 58. Israel Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 59. GCC Countries Compounding Pharmacy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 60. PharMEDium Services Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 61. B. Braun Group Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 62. Fagron Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 63. Wedgewood Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 64. New Compounding Pharma Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 65. Medisca Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 66. Fresenius Kabi Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 67. Advanced Pharma Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 68. AIN GROUP Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 69. Nihon Chouzai Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 70. Sogo Medical Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 71. Dougherty’s Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 72. Apollo Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 73. Downing Labs Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 74. Qol Holdings Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 75. Olympia Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 76. PUMCH Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 77. Triangle Compounding Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 78. Peking University First Hospital Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 79. Affiliated Hospital of Guangdong Public Institution of Medicine Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 80. Lorraine's Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 81. PLAGH Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 82. Institutional Pharmacy Solutions Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 83. Ruijin Hospital Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 84. Belle Sante Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 85. Byculla Pharmacy&Stores Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 86. Royal Chemists Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 87. Village Compounding Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 88. Specialist Pharmacy Revenue Growth Rate in Compounding Pharmacy Business (2019-2024)
 Figure 89. Bottom-up and Top-down Approaches for This Report
 Figure 90. Data Triangulation
 Figure 91. Key Executives Interviewed